Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 25, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Experimental rat bladder urothelial cell carcinoma models.

Harm C Arentsen1, Kees Hendricksen, Egbert Oosterwijk

  • 1Department of Urology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands. h.arentsen@uro.umcn.nl

World Journal of Urology
|February 17, 2009
PubMed
Summary

Bladder cancer frequently recurs and progresses despite treatment. This paper reviews current animal models and introduces a new orthotopic rat bladder tumor model for preclinical testing of intravesical therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting tumour and organ dose in α-radiopharmaceutical therapy: a <sup>89</sup>Zr-based dosimetric approach for <sup>225</sup>Ac.

European journal of nuclear medicine and molecular imaging·2026
Same author

Efficacy of combined targeted radionuclide therapy and immune checkpoint Inhibition in animal tumour models: a systematic review and meta-analysis of the literature.

European journal of nuclear medicine and molecular imaging·2025
Same author

Kinomic profiling to predict sunitinib response of patients with metastasized clear cell Renal Cell Carcinoma.

Neoplasia (New York, N.Y.)·2024
Same author

Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma.

Theranostics·2024
Same author

Growth Factor Immobilization to Synthetic Hydrogels: Bioactive bFGF-Functionalized Polyisocyanide Hydrogels.

Advanced healthcare materials·2023
Same author

Comparison of Osteogenic Capacity and Osteoinduction of Adipose Tissue-Derived Cell Populations.

Tissue engineering. Part C, Methods·2023

Area of Science:

  • Oncology
  • Urology
  • Preclinical Research

Background:

  • Bladder cancer presents a significant public health challenge.
  • Existing therapies are limited in preventing tumor recurrence and progression.
  • Effective preclinical models are crucial for developing novel intravesical treatments.

Purpose of the Study:

  • To critically evaluate limitations of current in vivo animal bladder cancer models.
  • To focus on the orthotopic syngeneic rat bladder tumor model.
  • To describe the development of a novel orthotopic rat bladder tumor model.

Main Methods:

  • Literature review of existing bladder tumor models.
  • Analysis of the orthotopic syngeneic rat model's suitability.
  • Description of a newly developed orthotopic rat bladder tumor model.

More Related Videos

An Orthotopic Model of Murine Bladder Cancer
09:07

An Orthotopic Model of Murine Bladder Cancer

Published on: February 6, 2011

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Experiment Videos

Last Updated: Jun 25, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

An Orthotopic Model of Murine Bladder Cancer
09:07

An Orthotopic Model of Murine Bladder Cancer

Published on: February 6, 2011

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Main Results:

  • Current in vivo models exhibit limitations in accurately mimicking human bladder cancer.
  • The orthotopic syngeneic rat bladder tumor model shows promise but requires refinement.
  • A new orthotopic rat model has been developed for improved preclinical evaluation.

Conclusions:

  • There is a critical need for improved animal models in bladder cancer research.
  • The developed orthotopic rat model offers a promising platform for testing new intravesical therapies.
  • Advancing bladder cancer treatment requires better preclinical models for drug development.